Press Releases

Health News Posted on Monday, November 6, 2017

Press Releases »

Let's Be Clear Georgia Applauds FDA Action on Medical Pot Companies Making Dishonest Medical Claims

FDA sends warning letters to four companies ATLANTA , Nov. 6, 2017 /PRNewswire-USNewswire/ -- The Food and Drug Administration (FDA) announced it was sending warning letters to companies illegally selling marijuana products with unsubstantiated medical claims. Let's Be Clear Georgia applauds...

Read More ...

Think Research to deliver comprehensive healthcare solutions on the IBM Cloud

TORONTO , Nov. 6, 2017 /CNW/ -   Think Research, a leading digital healthcare platform provider, today announced that it has partnered with IBM to drive further scalability for their suite of cloud-based clinical decision support tools using IBM Cloud. To address modern medical challenges, he...

Read More ...

Pitfalls in Anesthesia Billing Underscore the Need for Coding Compliance Risk Evaluation

Proper medical coding and billing for anesthesiology are far more complicated than for other medical specialties, and errors are easy to make. Compliance risk evaluation technology solutions help identify anesthesia coding errors to prevent revenue loss and limit liability. BROOKFIELD, Wis. , ...

Read More ...

Frantz Cosmetic Center Introduces UltraSlim® for Fat Loss and Body Contouring

FORT MYERS, Fla. , Nov. 6, 2017 /PRNewswire/ -- Who says you have to gain weight over the holidays? This holiday season, when you put on that little black dress, you can feel confident knowing you are looking better than ever! Frantz Cosmetic Center is excited to announce they are now offering...

Read More ...

Banner Alzheimer's Institute, Novartis, and Amgen Expand Collaboration in Pioneering Alzheimer's Prevention Program

Second study to probe whether an investigational drug can prevent or delay the emergence of symptoms in high-risk older adults PHOENIX , Nov. 6, 2017 /PRNewswire/ -- Researchers from the Banner Alzheimer's Institute (BAI), Novartis, and Amgen today announced another step forward in the inter...

Read More ...

Intravascular Temperature Management Market Worth 272.3 Million USD by 2022

PUNE, India , November 6, 2017 /PRNewswire/ -- According to a new market research report " Intravascular Temperature Management Market by Type (Warming, Cooling), Application (Perioperative, Post-operative, Acute Care), Medical Condition (Stroke, Cardiac Arrest, Traumatic Brain Injury (TBI),...

Read More ...

Takeda, Lundbeck and Advocate Health Care Research Study Aims to Enhance Patient-Provider Engagement in Major Depressive Disorder Treatment using Digital Technology

DEERFIELD, Ill. , Nov. 6, 2017 /PRNewswire/ -- Takeda Pharmaceuticals U.S.A. , Inc. (Takeda), Lundbeck U.S. and Advocate Health Care today announced a collaboration focusing on the use of digital technology to support people living with depression. "Patient Management of Depression thro...

Read More ...

Correct Care Solutions Celebrates 10 Years of Innovation

More than 300 Correctional Facilities Use CCS' Proprietary Electronic Medical Records to Deliver Quality Care NASHVILLE, Tenn. , Nov. 6, 2017 /PRNewswire-USNewswire/ -- Innovation is a critical component of Correct Care Solutions' work to deliver high quality health care to its patients. For...

Read More ...

Best-performing Clinical Applications in the Interventional X-ray Market

Value-based pricing, product differentiation, technology innovation and embracement of multi-modality integration in hospital segments continue to drive the demand, finds Frost & Sullivan SANTA CLARA, Calif. , Nov. 6, 2017 /PRNewswire/ -- The global interventional X-ray (IXR) equipment marke...

Read More ...

Lupus Research Alliance Prompted Stelara® Study for Lupus - Results Show Potential for New Treatment Option

NEW YORK , Nov. 6, 2017 /PRNewswire-USNewswire/ --  Lupus Research Alliance welcomes compelling new data, presented at the American College of Rheumatology (ACR) annual meeting that demonstrated significant benefit for lupus patients treated with Stelara® (ustekinumab), a prescription medici...

Read More ...

UCB Presents New Findings Advancing Patient Care for Chronic Inflammatory Diseases and Osteoporosis at 2017 ACR/ARHP Annual Meeting

BRUSSELS , Nov. 6, 2017 /PRNewswire/ -- Key data focus on inflammatory and osteoporosis in patient populations with unmet needs including women of childbearing age and others: The results from the first-of-its-kind CRIB study demonstrate minimal placental transfer of CIMZIA ® during pre...

Read More ...

Tech Company EmpiraMed Boosts Customer Domain Expertise by Hiring 2 Biopharmaceutical Industry Veterans

New Executives Have 37 Years of Combined Biopharmaceutical Experience in Clinical Research and Commercial Operations MAYNARD, Mass. , Nov. 6, 2017 /PRNewswire/ -- EmpiraMed, Inc., a leader in the field of patient engagement software to capture Real World Evidence, today announced that two ex...

Read More ...

New Survey Reveals Physical, Mental and Financial Challenges Faced by Caregivers in the United States

- Findings revealed at launch of Embracing Carers™, a global initiative to raise the awareness of the crucial role of caregivers ROCKLAND, Mass. , Nov. 6, 2017 /PRNewswire/ -- EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany , in the US and Canada, announced the re...

Read More ...

CytRx Announces Strategic Realignment of Clinical Development Team

LOS ANGELES , Nov. 6, 2017 /PRNewswire/ -- CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, today announced the strategic realignment of its drug development efforts for advancing new drug candidates based on its LADR™ (Linker Acti...

Read More ...

Introducing Powerdot, Paving The Way In Smart Muscle Stimulation

Discover The Powerful Benefits of Electrical Muscle Stimulation CARLSBAD, Calif. , Nov. 6, 2017 /PRNewswire/ -- Electrical muscle stimulation roots back to the 1970s, when it gained popularity due to high profile fans such as Bruce Lee and Muhammad Ali touting its transformative benefits. ...

Read More ...

Unsure About Biotech Gains Then Consider Medical Innovation Instead

USA News Group News Commentary LOS ANGELES , November 6, 2017 /PRNewswire/ -- While biotech and pharmaceutical firms may be taking the focus right now, for those unsure about the risk, medical device companies continue to provide some truly innovative offerings. Several companies in this s...

Read More ...

Orpheus Clinical Media Platform Expands Market Share and Product Offering

Leading Children’s Hospitals and Teaching Facilities use Orpheus for Mobile Image Capture and Video Management; New Software release for Point of Care Ultrasound and Web Platform for Endoscopy Documentation and Physician Reporting. CHICAGO , November 6, 2017 /PRNewswire/ -- International cl...

Read More ...

Debiopharm International SA Announces Dosing of First Patient in a Combination Trial of Debio 1143 and Avelumab in Patients with Solid Tumors including Non-Small Cell Lung Cancer (NSCLC)

The clinical trial is in collaboration with the alliance between Merck KGaA, Darmstadt, Germany and Pfizer LAUSANNE , Switzerland , November 6, 2017 /PRNewswire/ -- Debiopharm International SA (Debiopharm - http://www.debiopharm.com ), part of Debiopharm Group ™ , a Swiss-based global bio...

Read More ...

ABC Financial and Lead Dolphin Announce Vendor Relationship

LITTLE ROCK, Ark. , Nov. 6, 2017 /PRNewswire/ -- ABC Financial (ABC), the leading software and payment processing provider to the health and fitness industry, announced their preferred partnership with Lead Dolphin. Lead Dolphin is a lead management and member acquisition platform.  They have ...

Read More ...

Lianluo Smart Announces Strategic Investment in Guardion Health Sciences

BEIJING , Nov. 6, 2017 /PRNewswire/ -- Lianluo Smart Limited ("Lianluo Smart" or the "Company") (Nasdaq: LLIT) , a smart service and products provider in China, today announced that the Company and related party Digital Grid ( Hong Kong ) Technology Co., Limited ("Digital Grid") together inves...

Read More ...

Newly Published Research Shows That Dogs, Similar To Humans, Are Subject To Increased Cellular Damage & Inflammation As They Age

Additionally, an international survey finds that one in five dog owners have older dogs and majority want to understand their dogs' needs FRANKLIN, Tenn. , Nov. 6, 2017 /PRNewswire/ -- Mars Petcare, announced today the publication of a recently published study showing that dogs' immune syste...

Read More ...

CMEPP Saves Hospitals Over $2.5M in 2017 Through Smarter Healthcare Equipment Servicing and Repairs

Organization drives hard dollar savings that can be re-invested in patient care/quality TORONTO , Nov. 6, 2017 /CNW/ - Canada's  only not-for-profit organization dedicated to managing healthcare equipment service contracts, Canadian Medical Equipment Protection Plan (CMEPP), is pleased to a...

Read More ...

MYM Announces Closing of Second Tranche of Non-brokered Financing

VANCOUVER, British Columbia , Nov. 6, 2017 /PRNewswire/ -- MYM Nutraceuticals Inc., (CSE: MYM) (MYM.CN) (OTC:MYMMF) (the "Company" or "MYM") is pleased to announce that it has closed the second and final tranche of its non-brokered private placement of 771,000 units at a price of $0.50 per un...

Read More ...

Hearing Aids Market Worth 9.78 Billion USD by 2022

PUNE, India , November 6, 2017 /PRNewswire/ -- According to a new market research report " Hearing Aids Market by Product (Receiver In The Ear, Behind The Ear, In The Ear, In The Canal Hearing Aids, Cochlear Implant, BAHA implant), Types of Hearing Loss (Sensorineural, Conductive Hearing l...

Read More ...

Jockey Wins ANA Multicultural Excellence Award in the People with Disabilities Category

eSSENTIAL Accessibility Inaugurated the People with Disabilities Category Four Years Ago to Educate CMOs on Value of Being an Inclusive and Disability-Friendly Brand TORONTO , Nov. 6, 2017 /PRNewswire/ --  eSSENTIAL Accessibility , a digital accessibility services provider, today announced t...

Read More ...

Efficacy and safety maintained in patients who switched from Humira® to biosimilar Cyltezo®

- 48-week Phase III data showed Cyltezo and Humira have similar efficacy, safety and immunogenicity in people with rheumatoid arthritis RIDGEFIELD, Conn. , Nov. 6, 2017 /PRNewswire/ -- Boehringer Ingelheim today announced one-year data from VOLTAIRE®-RA , a pivotal Phase III clinical tria...

Read More ...

OCE Continues to Build Capacity in Healthcare-related Innovation Procurement

Second round of REACH projects announced TORONTO , Nov. 6, 2017 /CNW/ - Ontario Centres of Excellence (OCE) is pleased to announce six successful applicants for the second round of REACH (Resources for Evaluating, Adopting and Capitalizing on Innovative Healthcare Technology), an innovativ...

Read More ...

Health Canada Approves IMFINZI® (durvalumab) for Previously Treated Patients with Advanced Bladder Cancer

Approval granted based on promising tumour response rate and duration of response MISSISSAUGA, ON , Nov. 6, 2017 /CNW/ - AstraZeneca Canada today announced that Health Canada has approved Imfinzi® (durvalumab) for the treatment of advanced bladder cancer in previously treated patients. Imfin...

Read More ...

Eutilex and Huahai Enter Immuno-Oncology Partnership

Chinese Drugmaker Gets $30M Equity Stake, Licensing Rights to Potent Antibody SEOUL, South Korea , Nov. 6, 2017 /PRNewswire/ --  Eutilex Co. Ltd . today announced that it has entered into a strategic partnership with China's fast-growing Zhejiang Huahai Pharmaceutical Ltd. -- a deal that ...

Read More ...

Europe's Legal Cannabis Market is a €56 Billion Opportunity - Prohibition Partners

LONDON , November 6, 2017 /PRNewswire/ -- A new report from industry advisors, Prohibition Partners , suggests that Europe will become the largest legal cannabis market in the world once all countries have introduced legislation and regulation over the next five years. Cannabis is set to b...

Read More ...

Zygomatic and Pterygoid Implants Market to Attain a Value of US $350.2 Million by the End of 2025: Transparency Market Research

Zygomatic and Pterygoid Implants Market: Keen Players Take Acquisitions Route to Bolster Positions ALBANY, New York , November 6, 2017 /PRNewswire/ -- The zygomatic technique steals a march over conventional implant techniques on account of many unique perceived benefits. First, it takes ju...

Read More ...

Online community brings innovation offering to more than 2 million Québec caregivers

WE THE CARING: Through social connection, Huddol.com empowers caregivers to create better care experiences and health outcomes for themselves and their loved ones MONTREAL , Nov. 6, 2017 /CNW/ - At any given moment, more than 2 million Québec households are providing care to a family member o...

Read More ...

Neovasc Receives FDA Approval to Initiate Pivotal Reducer Trial

NASDAQ, TSX: NVCN VANCOUVER , Nov. 6, 2017 /PRNewswire/ - Neovasc Inc. (" Neovasc " or the " Company ") (NASDAQ, TSX: NVCN) announced that it has received approval of the U.S. Food and Drug Administration ("FDA") to initiate the COSIRA-II IDE pivotal clinical trial.  The trial's purpose will...

Read More ...

Compugen to Initiate Manufacturing of COM902, its Lead Anti-TIGIT Monoclonal Antibody

COM902 IND anticipated in 2019 to allow clinical testing of combination therapies with COM701 HOLON, Israel , Nov. 6, 2017 /PRNewswire/ --  Compugen Ltd. (NASDAQ: CGEN), a leader in predictive discovery and development of first-in-class therapeutics for cancer immunotherapy, today announced...

Read More ...

Cardinal Health Outlines Leadership Succession Plan

-- Mike Kaufmann Named Chief Executive Officer, Effective January 1, 2018 -- ...

Read More ...

Technical Insights on Biotech Stocks -- Cara Therapeutics, Catabasis Pharma, Cerus, and Genocea Biosciences

NEW YORK , Nov. 6, 2017 /PRNewswire/ -- If you want a Stock Review on CARA, CATB, CERS, or GNCA then come over to http://dailystocktracker.com/register/ and sign up for your free customized report. On Friday, benchmark US indices were in bullish colors as the NASDAQ Composite closed the tradi...

Read More ...

Guidewires Market Value to Reach US $2.7 Billion by the End of 2025: Transparency Market Research

Guidewires Market: Companies up Spends on Research and Development to Stay Ahead of Curve ALBANY, New York , November 6, 2017 /PRNewswire/ -- The global guidewires market is seeing a considerably degree of technological evolution because of efforts of savvy players to come up with more effe...

Read More ...

Soligenix Announces Recent Accomplishments And Third Quarter 2017 Financial Results

2017 Non-Dilutive Funding Exceeds $8M PRINCETON, N.J. , Nov. 6, 2017 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical nee...

Read More ...

Advancing research to reduce the cancer burden at the Canadian Cancer Research Conference

VANCOUVER , Nov. 6, 2017 /CNW/ - Researchers from across Canada will share discoveries at the 2017 Canadian Cancer Research Conference (CCRC), Canada's only national forum showcasing the entire spectrum of cancer research. The conference, hosted by the Canadian Cancer Research Alliance will...

Read More ...

STORM Therapeutics Strengthens Board with Appointment of Professor Paul Workman, President and CEO of The Institute of Cancer Research

CAMBRIDGE, England , November 6, 2017 /PRNewswire/ -- STORM Therapeutics, the drug discovery company focused on the discovery of small molecule therapies modulating RNA epigenetics, today announced the appointment of Professor Paul Workman to its Board. This appointment continues STORM's evo...

Read More ...

Ophthalmic Therapeutics Market Size Worth $35.7 Billion by 2025: Grand View Research, Inc.

SAN FRANCISCO , November 6, 2017 /PRNewswire/ -- The global  ophthalmic therapeutics/drugs market is expected to reach USD 35.7 billion by 2025, according to a new report by Grand View Research, Inc. Increase in funding by public and private bodies for conducting research on ocular disord...

Read More ...

Aeronutrix Hits the Sweet-spot for Tapping Into the Burgeoning Active-living OTC Nutrition Market

MUMBAI , November 6, 2017 /PRNewswire/ -- The FSSAI-approved, gluten-free and diabetic friendly - ' Fast&Up ', is rapidly emerging as the Brand of Choice in this fast growing, high-margin business. Mumbai -based Aeronutrix Sports Products Private Limited, is precipitating a momentous cha...

Read More ...

Switching to Tresiba® is Highly Cost-effective and Cost-saving in a Real-world Setting

GLASGOW, Scotland , November 6, 2017 /PRNewswire/ -- Poster Presentation PDB27 A new analysis of real-world data has shown that switching to Tresiba ® (insulin degludec) is highly cost-effective and cost-saving for the treatment of type 1 and type 2 diabetes, respectively. [1] The analysis ...

Read More ...

Enesi Pharma Appoints New International Scientific Advisory Board

OXFORD, England , November 6, 2017 /PRNewswire/ -- Enesi Pharma , a clinical-stage company developing unique injectable solid do se drug-device combination products, announces the formation of a new International Scientific Advisory Board (SAB). The SAB includes experts in vac...

Read More ...

Pharmaleads CEO to Present at Bio-Europe 2017

PARIS , November 6, 2017 /PRNewswire/ -- Pharmaleads, an emerging pharmaceutical company developing innovative non-opiate products for the management of acute and chronic severe pain, announces that CEO Thierry Bourbié will present a company and pipeline overview at Bio-Europe 2017 in Berli...

Read More ...

Advicenne Announces Positive 6-Month Extension Study Data from Pivotal Phase III Study of ADV7103 in Adults and Children Suffering from distal Renal Tubular Acidosis (dRTA)

NIMES, France , November 6, 2017 /PRNewswire/ -- - Data presented at the American Society of Nephrology (ASN) meeting in New Orleans - Positive data will form basis for application seeking market authorization of ADV7103 to the European Medicines Agency in Europe for dRTA expe...

Read More ...

NousCom Raises €42 Million Series B Financing

Financing to advance its pipeline of neoantigen cancer based immunotherapies to the clinic BASEL, Switzerland , November 6, 2017 /PRNewswire/ -- NousCom, an oncology company developing neoantigen based cancer vaccines based on its Exovax platform, today announced the completion of a €42 mil...

Read More ...

Glutenostics Launches Gluten Detective, the First At-Home Gluten Consumption Monitoring Test

LOS ANGELES , Nov. 6th, 2017 /PRNewswire/ -- Glutenostics LLC formally announced today the launch of their first product line, Gluten Detective, a rapid test suite for people on the gluten-free diet (GFD) to monitor compliance.  In just 15 minutes or more, in the privacy of a bathroom anywhere ...

Read More ...
More Press Releases

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store